Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965113 | Vaccine | 2015 | 6 Pages |
Abstract
Orally-delivered vaccines can provide long-term immune responses mucosally and systemically. For sexually-transmitted diseases that can be acquired at mucosal surfaces, such as HBV, an oral delivery platform may provide added protection over a conventional parenterally administered vaccine.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Celine A. Hayden, Maria E. Fischer, Bryan L. Andrews, Hayley C. Chilton, Debra D. Turner, John H. Walker, Ian R. Tizard, John A. Howard,